Bob Charles Receives 2019 George F. Linsteadt Technology Transfer (T2) Achievement Award

The FLC is proud to announce that former FLC Executive Board member Robert “Bob” Charles has been awarded the Department of Defense (DoD) 2019 George F. Linsteadt Technology Transfer (T2) Achievement Award.

For over 18 years, Charles has championed legal innovation in DoD’s T2 ecosystem. He sets standards for performing comprehensive yet timely legal reviews, provides practical business advice, and leads negotiations that continually result in successful Cooperative Research and Development Agreements (CRADAs) and license agreements for government-owned patents on medical products. Charles’ contributions consist of personally reviewing several hundred agreements annually, providing legal and policy advice nationally and internationally as the DoD subject-matter expert on CRADAs, and mentoring attorneys and T2 practitioners throughout the U.S. Government.

During his tenure as T2 transaction counsel, the U.S. Army’s Medical Research and Development Command’s (USAMRDC) laboratories have received over $360 million in CRADA revenues from non-federal partners, as well as countless millions more in other resources, speeding up medical research that benefits both the warfighter and global interest. For example, the result of CRADAs and patent license agreements he negotiated with two different commercial partners in 2018, both for prophylactic use, led to the approval of the Army-invented antimalarial drug, Tafenoquine, by the U.S. Food and Drug Administration (FDA) that year. Tafenoquine, a solution for the treatment of acute disease, is being applauded as a tremendous achievement for the U.S. military and its partners for their long and dedicated effort to provide global protection against malaria.

The recipient of the George F. Linsteadt award embodies the vision and spirit of Linsteadt and his proactive legacy in the shaping of the DoD’s T2 community. In receiving this award, Charles encapsulates George F. Linsteadt’s essence through his superior performance and commitment to duty, love and dedication to our nation’s warfighter, and promotion of innovation that stands out among his peers. Charles’ fortitude and unwavering professionalism are in keeping with the highest traditions of military modernization by greatly enhancing the DoD T2 program and reflecting great credit on the Defense Laboratory Enterprise and the United States military medical community.

A frequent speaker at FLC national meetings, Charles has contributed a great deal to the FLC and T2 community by sharing his T2 experience and expertise. In addition to serving on the FLC Executive Board as Legal Issues Committee chair from 2002 to 2010, Charles served as editor and contributor to several editions of the FLC Green Book and the T2 Desk Reference.
 
The FLC congratulates Charles on this well-deserved honor!

Category: 
FLC News